These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16428998)

  • 21. Nursing and midwifery practice for maintenance of vascular access device patency. A cross-sectional survey.
    Keogh S; Flynn J; Marsh N; Higgins N; Davies K; Rickard CM
    Int J Nurs Stud; 2015 Nov; 52(11):1678-85. PubMed ID: 26206327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review.
    Mitchell MD; Anderson BJ; Williams K; Umscheid CA
    J Adv Nurs; 2009 Oct; 65(10):2007-21. PubMed ID: 20568318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study.
    Arnts IJ; Heijnen JA; Wilbers HT; van der Wilt GJ; Groenewoud JM; Liem KD
    J Adv Nurs; 2011 Dec; 67(12):2677-85. PubMed ID: 21722168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing pediatric patients for vascular access and sedation.
    Earhart A; Jorgensen C; Kaminski D
    J Infus Nurs; 2007; 30(4):226-31. PubMed ID: 17667078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patency of arterial catheters with heparinized solutions versus non-heparinized solutions: a review of the literature.
    Lapum JL
    Can J Cardiovasc Nurs; 2006; 16(2):64-70. PubMed ID: 17153134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric i.v. catheters: efficacy of saline flush.
    Danek GD; Noris EM
    Pediatr Nurs; 1992; 18(2):111-3. PubMed ID: 1574361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparinized saline vs normal saline for maintenance of intravenous access in neonates: an evidence-based practice change.
    Cook L; Bellini S; Cusson RM
    Adv Neonatal Care; 2011 Jun; 11(3):208-15. PubMed ID: 21730915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversial issues in the care and maintenance of vascular access devices in the long-term/subacute care client.
    Sterba KG
    J Infus Nurs; 2001; 24(4):249-54. PubMed ID: 11507788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M; Heijboer H; van Woensel JB; de Haan RJ
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular nursing experience, practice knowledge, and beliefs: Results from the Michigan PICC1 survey.
    Chopra V; Kuhn L; Ratz D; Flanders SA; Krein SL
    J Hosp Med; 2016 Apr; 11(4):269-75. PubMed ID: 26717423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patency of 24-gauge peripheral intermittent infusion devices: a comparison of heparin and saline flush solutions.
    Mudge B; Forcier D; Slattery MJ
    Pediatr Nurs; 1998; 24(2):142-5, 149. PubMed ID: 9697567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing a community level research utilization intervention.
    Shively M; Riegel B; Waterhouse D; Burns D; Templin K; Thomason T
    Appl Nurs Res; 1997 Aug; 10(3):121-7. PubMed ID: 9274064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintaining the patency of transduced arterial and venous lines using 0.9% sodium chloride.
    Leighton H
    Intensive Crit Care Nurs; 1994 Mar; 10(1):23-5. PubMed ID: 8148603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of a mediastinal mass on the initial positioning of a peripherally inserted central venous catheter.
    Tamburro RF; Conner DT; Proctor KE; Butler CL; Britton LR
    J Infus Nurs; 2003; 26(2):92-6. PubMed ID: 12642797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of varying intervals between heparin flushes on pediatric catheter longevity.
    Crews BE; Gnann KK; Rice MH; Kee CC
    Pediatr Nurs; 1997; 23(1):87-91. PubMed ID: 9137028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric peripherally inserted central catheter program report: a summary of 4,536 catheter days.
    Frey AM
    J Intraven Nurs; 1995; 18(6):280-91. PubMed ID: 8699286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of heparin versus normal saline for maintenance of peripheral intravenous locks in pregnant women.
    Niesen KM; Harris DY; Parkin LS; Henn LT
    J Obstet Gynecol Neonatal Nurs; 2003; 32(4):503-8. PubMed ID: 12903700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripherally inserted central catheters: use at a tertiary care pediatric center.
    Gibson C; Connolly BL; Moineddin R; Mahant S; Filipescu D; Amaral JG
    J Vasc Interv Radiol; 2013 Sep; 24(9):1323-31. PubMed ID: 23876551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripherally inserted central catheters in the treatment of children with cancer: Results of a multicenter study.
    Rykov MY; Zaborovskij SV; Shvecov AN; Shukin VV
    J Vasc Access; 2018 Jul; 19(4):378-381. PubMed ID: 29546772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.